ISPUB.com / IJNW/1/2/5703
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Nutrition and Wellness
  • Volume 1
  • Number 2

Original Article

L-Ascorbic Acid Status Of Pregnant Women And Its Potential Role In Pregnancy-Induced Stress

I Garba, G Ubom, D Gatsing, R Aliyu, C Onyeagwa

Keywords

antioxidants, l-ascorbic acid, pregnancy, reactive oxygen species, stress

Citation

I Garba, G Ubom, D Gatsing, R Aliyu, C Onyeagwa. L-Ascorbic Acid Status Of Pregnant Women And Its Potential Role In Pregnancy-Induced Stress. The Internet Journal of Nutrition and Wellness. 2004 Volume 1 Number 2.

Abstract


Introduction: The increased metabolic activity during pregnancy leads to an increased oxygen requirement. This in turn leads to an increased intake and utilization of oxygen resulting in elevated levels of oxidative stress via the production of reactive oxygen species.
Methods: The concentration of serum L-ascorbic acid was assayed in 90 pregnant women (age range 20-35 years) and a control group of 30 age-matched women with the aim of assessing the variation in L-ascorbic acid levels and its availability for scavenging reactive oxygen species and controlling oxidative stress during pregnancy.
Results: Serum L-ascorbate was found to generally decrease during the entire period of pregnancy. Inter-trimester mean L-ascorbic acid concentrations in serum were all lower than the control serum L-ascorbic acid concentration. The lowest serum concentration of L-ascorbic acid was found in the first trimester, 1.10 ± 0.01 mg/dl, p < 0.05 relative to the control serum L-ascorbic acid concentration of 3.05 ± 0.13 mg/dl. Within trimester L-ascorbate was lowest in the 1-2 months of pregnancy, 0.84 ± 0.01 mg/dl vs. 3.05 ± 0.13 mg/dl (control), p < 0.05.
Conclusion: These results indicate a compromised ability to scavenge reactive oxygen species, significant perturbation of other L-ascorbate-requiring metabolic/physiological activities during pregnancy and the need for vitamin C supplementation for pregnant women.

 

Introduction

Many free radicals are produced in the body as a result of the myriad of biochemical processes taking place in normal metabolism 1. Oxygen-derived free radical s account for 95 % of such radicals 2. These free radicals perform some physiologic function to some degree in the body such as, participating in xenobiotics metabolism, biosynthesis and clearance of microorganisms 3,4,5. The normal homeostasis of these free radicals is maintained by anti-oxidants and anti-oxidases, leading to a dynamic balance between production and clearance 6. An imbalance between reactive oxygen species and anti-oxidant defense mechanisms of a cell leads to an excessive production of oxygen metabolites, creating a condition known as ‘oxidative stress' 7. Such free radicals can attack polyunsaturated fatty acids of membranes, leading to lipid peroxidation and disruption of intracellular calcium homeostasis and consequent cellular apoptosis 8. Free radicals can also destroy key intracellular enzymes, including free radical scavenger enzymes, disrupt DNA replication and initiate the process of carcinogenesis 9,10.

Free radical-induced oxidative injury have been reported to have a role in the pathogenesis of a number of diseases, including cancer, atherosclerosis, diabetes mellitus, epilepsy, radiation damage, cellular aging, reperfusion damage, inflammatory diseases and Parkinsonism 2, 10,11,12,13,14,15. Free radical defenses in the body consist of a complex anti-oxidant system comprising of vitamins A, C, E, glutathione and anti-oxidant enzymes 16,17. These enzymes include glutathione reductase, glutathione peroxidase, superoxide dismutase and catalase 16. Pregnancy is a developmental crisis in a woman's life. It places a great demand on her body and requires adaptation. Changes in many of the body's biochemical function during pregnancy leads to a high demand for energy and an increased oxygen requirement 18. This leads to intake and utilization of oxygen, resulting in increased levels of oxidative stress and the consequent acceleration in the production of reactive oxygen species 19. In this study, the serum concentration of L-ascorbic acid which makes up over 80% of the vitamin C activity was assessed in pregnant women in three different trimesters of pregnancy with the aim of determining the effect of pregnancy on serum L-ascorbic acid concentration and its availability for the scavenging of reactive oxygen species produced as a result of pregnancy-induced oxidative stress.

Subjects And Methods

Subjects. The subjects enrolled in this study comprised of 90 pregnant women (30 in each trimester) within the age range of 20-35 years. 30 age and sex-matched non-pregnant adult females were also enrolled for comparative studies. None of the study or control subjects had taken any form of vitamin C supplementation within a period of two weeks prior to participation in the study.

Assay for serum vitamin C. Serum L-ascorbic acid was assayed using the 2, 6-dichlorophenolindophenol method 20.

Ethics. The study was conducted in compliance with the Lisbon Declaration on the Rights of the Patient 21.

Data analysis. Data are presented as mean ± SEM. Data analysis was done using the Minitab-10 Statistical Software. Mean serum L-ascorbic acid concentration within and between trimesters were compared using One-Way ANOVA. The method of Least Significant Difference (LSD) was used to assess for significant differences between means where the ANOVA results returns a p value < 0.05. p values < 0.05 were considered significant.

Results

Figure 1
Table 1: Serum L-ascorbic acid concentration within first trimester (mg/dl).

Figure 2
Table 2: Serum L-ascorbic acid concentration within second trimester (mg/dl).

Figure 3
Table 3: Serum L-ascorbic acid concentration within third trimester (mg/dl).

Figure 4
Table 4: Inter trimester variation in mean serum L-ascorbic acid concentration (mg/dl).

The results obtained are shown in tables 1-4. Within the first trimester, serum L-ascorbic acid concentration is lowest in the 1 – 2 months of pregnancy. The mean serum L-ascorbic acid in this period was found to be 0.84 ± 0.01 mg/dl. It is significantly lower than the mean serum L-ascorbic acid concentration in the third month of pregnancy. Compared to the serum L-ascorbic acid in the controls, the serum L-ascorbic acid concentration within the first trimester of pregnancy is significantly lower, p < 0.05, table 1. The second trimester L-ascorbic acid concentrations in serum are higher than the mean L-ascorbic acid concentration obtained in the first trimester. The peak L-ascorbic acid concentration within this trimester was obtained in the fifth month of pregnancy as shown in table 2. The mean L-ascorbic acid concentrations within the second trimester are all however lower than the control serum L-ascorbic acid concentration of 3.05 ± 0.13 mg/dl, p < 0.05. The L-ascorbic acid concentrations within the last three months of the third trimester are within the same range except for the 8th month where a value of 1.30 ± 0.06 mg/dl was obtained, table 3. The control value of 3.05 ± 0.13 mg/dl is significantly higher than all the mean L-ascorbic acid concentrations within the last three months of pregnancy, p < 0.05. The inter-trimester comparison of the mean L-ascorbic acid concentrations shows a peak L-ascorbic acid value of 2.42 ± 0.13 mg/dl in the second trimester. This is significantly higher than the mean values for both first and third trimesters. The values are all lower than the control L-ascorbic acid concentration as shown in table 4, p < 0.05.

Discussion

There is a significant reduction in the serum L-ascorbic acid concentration throughout the period of pregnancy with the highest decrease in the first trimester. As reported by Renata et al.19 changes in the physiological state during pregnancy necessitates an increase oxygen intake and utilization. This leads to an increased level of oxidative stress. The increased utilization of L-ascorbic acid to neutralize the toxicity of the resulting reactive oxygen species consequent to increased oxidative stress can account for the low serum concentration of this vitamin. L-ascorbic acid is also involved in maintaining the tocopherol cycle, necessary for the peroxyl radical scavenging action of vitamin E in the biological lipid phase 22. Low serum L-ascorbic acid can therefore lead to a compromised defense against free radical-induced lipid peroxidation. Lipid peroxidation is known to be potentially harmful because its uncontrolled, self-enhancing process causes disruption of membranes, lipids and other cell components 23. The simultaneous decrease in L-ascorbic acid and the accompanying ineffectual vitamin E free radical scavenger function can cause damage to cellular organelles and lead to oxidative stress during pregnancy with undesirable effects on fetal development and maternal health. Considering the catalytic role of ascorbic acid in enhancing iron absorption 24,25 the low serum ascorbate can lead to a decrease in the absorption and subsequent utilization of iron which is required for the proper maintenance of pregnancy and fetal growth. In addition, during pregnancy resistance to infection is generally decreased. Similarly fetal and neonatal immunity is low. Low serum L-ascorbic acid will further complicate this delicate immune status since L-ascorbic acid is known to play a significant role in boosting immunity 26,27. Since earlier reports have confirmed the importance of vitamin C in safe delivery and the prevention of premature abortions 28,29 we conclude from these results that pregnant women should be placed on daily supplemental doses of vitamin C to boost maternal antioxidant defenses and help improve maternal and fetal immune status.

Correspondence to

Garba I.H. Email: ihgarba2002@yahoo.com Telephone: 0804-5252-720

References

1. Skaper SD, Fabris M, Ferrari V, Carbonare MD, Leon A. Quercetin protects cutaneous tissue-associated cell types from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Rad Biol Med 1997; 22: 669-678.
2. Du WD, Yuan ZR, Sun J, Tang JX, Cheng AQ, Shen DM, Song XH, Yu XF, Zheng SB. Therapeutic efficacy of high dose vitamin C on acute pancreatitis and its potential mechanisms. World J Gastroenterol 2003; 11: 2565-2569.
3. Braganza JM, Scott P, Bilton G, Schofield D, Chaloner C, Shiel N, Hunt LP, Bottiglieri T. Evidence for early oxidative stress in acute pancreatitis. Clues for correction. Int J Pancreatol 1995; 17: 69-81.
4. Wereszczynska S, Dabrowski A, Jedynak M, Gabryelewicz A. Oxidative stress as an early prognostic factor in acute pancreatitis (AP): its correlation with serum phospholipase A2 (pla2) and plasma polymorphonuclear elastase (PMN-E) in different severity forms of human AP. Pancreas 1998; 17: 163-168.
5. Fentone JC, Ward PA. Role of oxygen derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982; 107: 397-418.
6. Sudha K, Rao AV, Rao S, Rao A. Free radical toxicity and antioxidants in Parkinson's disease. Neurol India 2003; 51: 60-61.
7. Sudha K, Rao AV, Rao A. Oxidative stress and antioxidants in epilepsy. Clin Chim Acta 2001; 303: 19-24.
8. Buttke TM, Sandsrom PA. Oxidative stress as mediator of apoptosis. Immunol Today 1994; 15: 7-10.
9. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J 1996; 313: 17-29.
10. Sundstrom H, Korpela H, Viinikka L, Kauppila A. Serum selenium and GP and plasma lipid peroxides in uterine, ovarian and vulvar cancer, and their responses to antioxidants in patients with ovarian cancer. Cancer Lett 1984; 24: 1-10.
11. Plachta H, Bartkowska E, Obara A. Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries. Clin Chim Acta 1992; 211: 101-102.
12. Oberley LW. Free radicals and diabetes. Free Rad Biol Med 1988; 5: 113-124.
13. Bowling AC, Beal MF. Bioenergetics and oxidative stress in neurodegenerative diseases. Life Sci 1995; 56: 1151-1171.
14. Ames BN, Shigenaga MK, Hagen TM. Antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90: 7915-7922.
15. Yondim MB, Riederer P. Understanding Parkinson's disease. Sci Am 1997; 1: 38-45.
16. Halliwell B, Gutteridge JMC. The antioxidants of human extracellular fluids. Arch Biochim Biophys 1990; 280: 1-8.
17. Bravenboer B, Kapelle AC, Hamers EPT, Van Buren DW, Erkelens DW, Gispen WH. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozocin-induced diabetic rat. Diabetologia 1992; 35: 813-817.
18. Bray JJ, Cragg PA, Macknight ADC, Mills RG. Lecture notes on human physiology, 4th ed. Blackwell Scientific Publications, USA. 1999.
19. Renata G, Miroslow K, Wlodizimierz K, Ryszard K, Ewa S. Changes in antioxidant components in blood of mares during pregnancy and after foaling. Bull Vet Inst Pulaway 2002; 46: 301-305.
20. Plummer D. Introduction to practical Biochemistry. Oxford: Oxford University Press: 1971: 293.
21. World Medical Association. Declaration on the rights of the patient, Amended by the 43rd General Assembly, Bali Indonesia, 1995.
22. Sies H, Stahl W. Vitamins E and C, beta-carotene, and other carotinoids as antioxidants. Am J Clin Nutr 1995; 62: 1315-1321.
23. Mahboob M, Rahman MF, Grover P. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singapore Med J 2005; 46: 322-324.
24. Sharma DC, Mathur R. Correction of anaemia and iron deficiency in vegetarians by administration of ascorbic acid. Indian J Physiol Pharmacol 1996; 39: 403-406.
25. Whitney EA, Hamilton EMW. Understanding Nutrition. 3rd ed. Minnesota: West Publishing Company, 1984.
26. Thomas WR, Holt PG. Vitamin C and immunity: an assessment of the evidence. Clin Exptl Immunol 1978; 32: 370-378.
27. Fraser CR, Pavlovic S, Kurahara CG et al. The effect of variations in vitamin C intake on the cellular immune response in guinea pigs. Am J Clin Nutr 1980; 33: 839-847.
28. Klenner RF. Significance of high daily intake of ascorbic acid in preventive medicine. J Int Acad Prev Med 1974; 1: 45-69.
29. Klenner RF. Observations on the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology. J Appl Nutr 1971; 23: 1-31.

Author Information

I. H. Garba
Chemistry Programme, School of Science, Abubakar Tafawa Balewa University

G. A. Ubom
Department of Biochemistry, Faculty of Medical Sciences, University of Jos

D. Gatsing
Department of Biochemistry, Faculty of Science, University of Dschang

R. Aliyu
Department of Biochemistry, Faculty of Medical Sciences, University of Jos

C. D. Onyeagwa
Chemistry Programme, School of Science, Abubakar Tafawa Balewa University

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy